Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats.
Ying Yang, Hui Fang, Gang Xu, Yan-Feng Zhen +5 more
Researcher profile · Semantic Scholar
Ying Yang, Hui Fang, Gang Xu, Yan-Feng Zhen +5 more
Gang Xu, Takuya Watanabe, Y. Iso, S. Koba +8 more
Geng-Yin Wang, Hui Fang, Yan-Feng Zhen, Gang Xu +10 more
Toshiaki Suguro, Takuya Watanabe, S. Kodate, Gang Xu +3 more
Yan-Feng Zhen, Xing-Yu Liu, Dong-Hao Zhou, Xiangdong Du +6 more
Xiao-Xiao Wang, Hui Fang, Gang Xu, Ying Yang +5 more
Hui Fang, Xiaoyu Xu, Ruizhe Xu, Yan-Feng Zhen +2 more
Mei-Liu Yang, Lu Bai, Wu Yu, Xue-Ling Sun +7 more
Hui Fang, Yan-Feng Zhen, Xing-Yu Liu, Gang Xu +3 more
B. Zheng, D. Cheng, Gang Xu, Li-li Fan +2 more
Takuya Watanabe, Y. Iso, S. Koba, T. Sakai +6 more
Xiao-Xiao Wang, Hui Fang, Gang Xu, Ying Yang +5 more
Xiaoshuang Liu, Hui Fang, Yumei Zhou, X. Hao +3 more
X. Hao, Hui Fang, Ruizhe Xu, Gang Xu +5 more
Yumei Zhou, Yin-sheng Guo, Hui Fang, Gang Xu +2 more
Yu-Kai Li, Hui Fang, Yan-Feng Zhen, Gang Xu +4 more
Yu-Kai Li, Hui Fang, Yan-Feng Zhen, Gang Xu +5 more
Hui Fang, Ying Yang, Gang Xu, Ru-Hua Guan +2 more